These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10190221)

  • 1. Schizoaffective disorder: role of atypical antipsychotics.
    Keck PE; McElroy SL; Strakowski SM
    Schizophr Res; 1999 Mar; 35 Suppl():S5-12. PubMed ID: 10190221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM; West SA
    Psychopharmacology (Berl); 1994 May; 114(4):529-38. PubMed ID: 7855214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM
    J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the treatment of schizoaffective disorder.
    McElroy SL; Keck PE; Strakowski SM
    J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of hospitalized patients with schizoaffective disorder.
    Flynn J; Grieger TA; Benedek DM
    Psychiatr Serv; 2002 Jan; 53(1):94-6. PubMed ID: 11773657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics in bipolar and schizoaffective disorders.
    Brown ES; Thomas NR; Carmody T; Mahadi S; Nejtek VA
    Pharmacopsychiatry; 2001 Mar; 34(2):80-1. PubMed ID: 11302568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching antipsychotic therapies.
    Masand PS; Berry SL
    Ann Pharmacother; 2000 Feb; 34(2):200-7. PubMed ID: 10676829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.
    Ghaemi SN; Goodwin FK
    J Clin Psychopharmacol; 1999 Aug; 19(4):354-61. PubMed ID: 10440464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of schizoaffective disorders.
    Goodnick PJ; Meltzer HY
    Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.
    Blessing E; Kader L; Arpandy R; Ootsuka Y; Blessing WW; Pantelis C
    Aust N Z J Psychiatry; 2011 Aug; 45(8):646-53. PubMed ID: 21870922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The psychotic states in the psychiatric emergency].
    Herbst L
    Vertex; 2002; 13 Suppl 1():22-7. PubMed ID: 12122424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.